Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Greenamyre

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Neurobiology of Aging|July 1, 1991
Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: "use it and lose it"J T Greenamyre
Archives of Neurology|October 1, 1986
The role of glutamate in neurotransmission and in neurologic diseaseJ T Greenamyre
Current Opinion in Neurology|August 1, 1994
Recent developments in the cause and treatment of movement disordersJ T Greenamyre
Journal of Neural Transmission. General Section|January 1, 1993
Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's diseaseJ T Greenamyre
Functional Neurology|August 5, 2000
"Ottorino Rossi" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiologyJ T Greenamyre
Clinical Neuropharmacology|April 18, 2001
Glutamatergic influences on the basal gangliaJ T Greenamyre
Annals of Neurology|May 1, 1996
Pharmacological pallidotomy with glutamate antagonistsJ T Greenamyre
Analytical Biochemistry|September 1, 1995
Assay of [3H]dihydrorotenone binding to complex I in intact human plateletsF Blandini, J T Greenamyre
Neurology|December 13, 2000
A therapeutic target and biomarker in Friedreich's ataxiaT Sherer, J T Greenamyre
Neuroscience Letters|June 2, 1995
Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acidC Davolio, J T Greenamyre
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Neurobiology of Aging|July 1, 1991
Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: "use it and lose it"J T Greenamyre
Archives of Neurology|October 1, 1986
The role of glutamate in neurotransmission and in neurologic diseaseJ T Greenamyre
Current Opinion in Neurology|August 1, 1994
Recent developments in the cause and treatment of movement disordersJ T Greenamyre
Journal of Neural Transmission. General Section|January 1, 1993
Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's diseaseJ T Greenamyre
Functional Neurology|August 5, 2000
"Ottorino Rossi" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiologyJ T Greenamyre
Clinical Neuropharmacology|April 18, 2001
Glutamatergic influences on the basal gangliaJ T Greenamyre
Annals of Neurology|May 1, 1996
Pharmacological pallidotomy with glutamate antagonistsJ T Greenamyre
Analytical Biochemistry|September 1, 1995
Assay of [3H]dihydrorotenone binding to complex I in intact human plateletsF Blandini, J T Greenamyre
Neurology|December 13, 2000
A therapeutic target and biomarker in Friedreich's ataxiaT Sherer, J T Greenamyre
Neuroscience Letters|June 2, 1995
Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acidC Davolio, J T Greenamyre
Pageof 10